- Home
- LEGN vs CFR Comparison
LEGN vs CFR Comparison
Compare LEGN & CFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGN
- CFR
- Stock Information
- Founded
- LEGN 2014
- CFR 1868
- Country
- LEGN United States
- CFR United States
- Employees
- LEGN N/A
- CFR N/A
- Industry
- LEGN Biotechnology: Pharmaceutical Preparations
- CFR Major Banks
- Sector
- LEGN Health Care
- CFR Finance
- Exchange
- LEGN Nasdaq
- CFR Nasdaq
- Market Cap
- LEGN 6.7B
- CFR 8.0B
- IPO Year
- LEGN 2020
- CFR N/A
- Fundamental
- Price
- LEGN $33.11
- CFR $127.58
- Analyst Decision
- LEGN Strong Buy
- CFR Hold
- Analyst Count
- LEGN 12
- CFR 16
- Target Price
- LEGN $73.36
- CFR $136.50
- AVG Volume (30 Days)
- LEGN 1.1M
- CFR 439.8K
- Earning Date
- LEGN 11-11-2025
- CFR 10-30-2025
- Dividend Yield
- LEGN N/A
- CFR 3.12%
- EPS Growth
- LEGN N/A
- CFR 13.33
- EPS
- LEGN N/A
- CFR 9.29
- Revenue
- LEGN $796,838,000.00
- CFR $2,079,741,000.00
- Revenue This Year
- LEGN $70.75
- CFR $13.32
- Revenue Next Year
- LEGN $52.47
- CFR $4.15
- P/E Ratio
- LEGN N/A
- CFR $13.78
- Revenue Growth
- LEGN 74.75
- CFR 6.87
- 52 Week Low
- LEGN $27.34
- CFR $100.31
- 52 Week High
- LEGN $52.31
- CFR $147.64
- Technical
- Relative Strength Index (RSI)
- LEGN 36.16
- CFR 47.18
- Support Level
- LEGN $33.20
- CFR $125.40
- Resistance Level
- LEGN $34.71
- CFR $130.30
- Average True Range (ATR)
- LEGN 1.22
- CFR 2.28
- MACD
- LEGN -0.09
- CFR -0.12
- Stochastic Oscillator
- LEGN 10.96
- CFR 29.34
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About CFR Cullen/Frost Bankers Inc.
Cullen/Frost is a regional US bank with around $50 billion in assets (as of mid-2025), and it focuses exclusively on the Texas market. The bank has deep expertise in this market. It has implemented a relationship-based approach to banking that has garnered a strong market share in San Antonio. Cullen/Frost is also expanding into Houston, Dallas, and Austin market regions through branch openings. The bank's sweet spot is small to medium-size Texas-based commercial clients.